Usefulness of C-reactive protein/albumin ratio as a predictor of new-onset atrial fibrillation in SARS coronavirus-2

KELEŞOĞLU Ş., Yilmaz Y., Ozkan E., Calapkorur B., Dursun Z. B., ULU KILIÇ A., ...Daha Fazla

BIOMARKERS IN MEDICINE, cilt.15, sa.13, ss.1167-1176, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 15 Sayı: 13
  • Basım Tarihi: 2021
  • Doi Numarası: 10.2217/bmm-2020-0866
  • Dergi Adı: BIOMARKERS IN MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Chemical Abstracts Core, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.1167-1176
  • Anahtar Kelimeler: C-reactive protein, albumin ratio, new-onset atrial fibrillation, SARS-CoV-2, LYMPHOCYTE RATIO, ELEVATION, PROTEIN, CARDIOVERSION, INFLAMMATION, ASSOCIATION, NEUTROPHIL, RECURRENCE
  • Erciyes Üniversitesi Adresli: Evet

Özet

Aim: To investigate whether C-reactive protein/albumin ratio (CAR) has an association with new onset atrial fibrillation (NOAF) in SARS-CoV-2. Materials & methods: This study included 782 patients with SARS-CoV-2 infection, who were hospitalized in Turkey. The end point of the study was an occurrence of NOAF. Results: NOAF was identified in 41 patients (5.2%). Subjects who developed NOAF had a higher CAR compared with those who did not develop NOAF (p < 0.001). In the multivariate logistic regression analysis the CAR (odds ratio = 2.879; 95% CI: 1.063-7.793; p = 0.037) was an independent predictor of NOAF. Conclusion: A high level of CAR in blood samples is associated with an increased risk of developing NOAF in SARS-CoV-2.